Immune Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$130.00B

881 transactions

Summary

Immune Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $577KSales: —11 insiders

Date	Insider	Type	Value
2023-02-10	Farmer Glen A(Chief Financial Officer)	Buy	$20K
2017-12-28	Gostanian Richard	Buy	$600
2017-12-19	DAILEY ROBERT JACKMAN	Buy	$500
2017-12-13	Gostanian Richard	Buy	$500
2017-12-27	Gostanian Richard	Buy	$400
2017-12-11	Gostanian Richard	Buy	$300
2017-12-27	Gostanian Richard	Buy	$200
2017-12-27	Gostanian Richard	Buy	$200
2017-12-19	DAILEY ROBERT JACKMAN	Buy	$200
2017-12-13	Gostanian Richard	Buy	$150
2017-12-11	Gostanian Richard	Buy	$150
2017-12-08	Gostanian Richard	Buy	$126
2017-12-15	DAILEY ROBERT JACKMAN	Buy	$50
2017-12-13	DAILEY ROBERT JACKMAN	Buy	$50
2017-12-08	Gostanian Richard	Buy	$25
2021-05-28	Griffin Noreen	J	$0
2021-05-28	Griffin Noreen	J	$0
2021-05-28	Griffin Noreen	J	$0
2021-05-28	Griffin Noreen	J	$0
2021-05-28	Griffin Noreen	J	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Immune Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope